Earlier stage 3 clinical trials confirmed that tirzepatide, which is marketed beneath the model names Mounjaro as well as lately permitted Zepbound, resulted in a twenty% or higher weight loss after seventy two months when compared with a Manage team which was having a placebo.The main GLP-one receptor agonist reached the marketplace over a decade